These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 10803861)

  • 1. Losartan: a review of its use, with special focus on elderly patients.
    Simpson KL; McClellan KJ
    Drugs Aging; 2000 Mar; 16(3):227-50. PubMed ID: 10803861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II type 1 receptor antagonists in the treatment of hypertension in elderly patients: focus on patient outcomes.
    Tadevosyan A; Maclaughlin EJ; Karamyan VT
    Patient Relat Outcome Meas; 2011 Jul; 2():27-39. PubMed ID: 22915967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Foreword to updates on the treatment of elderly patients with heart failure].
    Nihon Ronen Igakkai Zasshi; 2024; 61(2):123. PubMed ID: 38839308
    [No Abstract]   [Full Text] [Related]  

  • 4. Refining the diagnosis of acute heart failure in the elderly.
    Riccardi M; Pagnesi M
    ESC Heart Fail; 2024 Aug; ():. PubMed ID: 39135432
    [No Abstract]   [Full Text] [Related]  

  • 5. Losartan potassium: a review of its pharmacology, clinical efficacy and tolerability in the management of hypertension.
    Goa KL; Wagstaff AJ
    Drugs; 1996 May; 51(5):820-45. PubMed ID: 8861549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A risk-benefit assessment of losartan potassium in the treatment of hypertension.
    Burrell LM
    Drug Saf; 1997 Jan; 16(1):56-65. PubMed ID: 9010643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study on the efficacy and safety of losartan in elderly patients with mild to moderate essential hypertension.
    Fernández-Vega F; Abellan J; Sanz de Castro S; Cucalón JM; Maceira B; Gómez de la Cámara A
    Int Urol Nephrol; 2001; 32(4):519-23. PubMed ID: 11989539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical pharmacokinetics of losartan.
    Sica DA; Gehr TW; Ghosh S
    Clin Pharmacokinet; 2005; 44(8):797-814. PubMed ID: 16029066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of losartan.
    Goldberg A; Sweet C
    Can J Cardiol; 1995 Aug; 11 Suppl F():27F-32F. PubMed ID: 7664215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Losartan potassium lowers blood pressure measured by ambulatory blood pressure monitoring.
    Byyny RL
    J Hypertens Suppl; 1995 Jul; 13(1):S29-33. PubMed ID: 18800453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative antihypertensive effects of losartan 50 mg and losartan 50 mg titrated to 100 mg in patients with essential hypertension.
    Ikeda LS; Harm SC; Arcuri KE; Goldberg AI; Sweet CS
    Blood Press; 1997 Jan; 6(1):35-43. PubMed ID: 9116924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of missed doses of amlodipine and losartan on blood pressure in older hypertensive patients.
    de Leeuw PW; Fagard R; Kroon AA
    Hypertens Res; 2017 Jun; 40(6):568-572. PubMed ID: 28100922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beneficial effects of the combination of amlodipine and losartan for lowering blood pressure in spontaneously hypertensive rats.
    Choi SM; Seo MJ; Kang KK; Kim JH; Ahn BO; Yoo M
    Arch Pharm Res; 2009 Mar; 32(3):353-8. PubMed ID: 19387578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The safety of long-term administration of losartan in current clinical practice: a non-intervention NCT-CZ 14/04/LOZ study].
    Krupicka J; Ceypová K; Kristenová P; Hauser T
    Vnitr Lek; 2008 Nov; 54(11):1031-8. PubMed ID: 19069675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Losartan: Comprehensive Profile.
    Al-Majed AR; Assiri E; Khalil NY; Abdel-Aziz HA
    Profiles Drug Subst Excip Relat Methodol; 2015; 40():159-94. PubMed ID: 26051686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of losartan 100 mg or losartan 100 mg plus hydrochlorothiazide 25 mg in the treatment of patients with essential arterial hypertension and CV risk factors: observational, prospective study in primary care.
    Bönner G; Smolka W; Jung C; Bestehorn K
    Curr Med Res Opin; 2009 Apr; 25(4):981-90. PubMed ID: 19254206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of the long-term treatment with losartan and captopril and of the abrupt cessation on circadian blood pressure profile].
    Gorbunov VM; Savina LV; Metelitsa VI; Deev AD
    Eksp Klin Farmakol; 2001; 64(2):45-50. PubMed ID: 11548448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of telmisartan versus losartan: meta-analysis of titration-to-response studies.
    Smith DH; Cramer MJ; Neutel JM; Hettiarachchi R; Koval S
    Blood Press Monit; 2003 Jun; 8(3):111-7. PubMed ID: 12900588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Losartan/hydrochlorothiazide combination is safe and effective for morning hypertension in Very-Elderly patients.
    Uchiwa H; Kai H; Iwamoto Y; Anegawa T; Kajimoto H; Fukuda K; Imaizumi T; Fukumoto Y;
    Clin Exp Hypertens; 2018; 40(3):267-273. PubMed ID: 29083936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.